Literature DB >> 23879211

Combining risk markers improves cardiovascular risk prediction in women.

Suzanne Holewijn1, Martin den Heijer, Lambertus A Kiemeney, Anton F H Stalenhoef, Jacqueline de Graaf.   

Abstract

Cardiovascular risk stratification could be improved by adding measures of atherosclerosis to current risk scores, especially in intermediate-risk individuals. We prospectively evaluated the additive value of different non-invasive risk markers (both individual and combined) for gender-specific cardiovascular risk stratification on top of traditional risk factors in a middle-aged population-based cohort. Carotid-plaques, IMT (intima-media thickness), ABI (ankle-brachial index), PWV (pulse-wave velocity), AIx (augmentation index), CAP (central augmented pressure) and CSP (central-systolic pressure) were measured in 1367 CVD (cardiovascular disease)-free participants aged 50-70 years old. Cardiovascular events were validated after a mean follow-up of 3.8 years. AUC (area-under-the-curve) and NRI (net reclassification improvement) analyses (total-NRI for all and clinical-NRI for intermediate-risk groups) were used to determine the additive value of individual and combined risk markers. Cardiovascular events occurred in 32 women and 39 men. Traditional cardiovascular risk factors explained 6.2% and 12.5% of the variance in CVD in women and men respectively. AUCs did not substantially increase by adding individual or combined non-invasive risk markers. Individual risk markers only improved reclassification in intermediate-risk women and more than in men; clinical-NRIs ranged between 48.0 and 173.1% in women and 8.9 and 20% in men. Combined non-invasive-risk markers improved reclassification in all women and even more in those at intermediate risk; 'IMT-presence-thickness-of-plaques' showed largest reclassification [total-NRI=33.8%, P=0.012; IDI (integrated-discrimination-improvement)=0.048, P=0.066; clinical-NRI=168.0%]. In men, combined non-invasive risk markers improved reclassification only in those at intermediate risk; 'PWV-AIx-CSP-CAP-IMT' showed the largest reclassification (total-NRI=14.5%, P=0.087; IDI=0.016, P=0.148; clinical-NRI=46.0%). In all women, cardiovascular risk stratification improved by adding combinations and in women at intermediate risk also by adding individual non-invasive risk markers. The additive value of individual and combined non-invasive risk markers in men is limited to men at intermediate risk only, and to a lesser extent than in women.

Entities:  

Mesh:

Year:  2014        PMID: 23879211     DOI: 10.1042/CS20130178

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

1.  The Association between Trimethylamine N-Oxide and Its Predecessors Choline, L-Carnitine, and Betaine with Coronary Artery Disease and Artery Stenosis.

Authors:  Fei Guo; Jun Zhou; Zhenyu Li; Zaixin Yu; Dongsheng Ouyang
Journal:  Cardiol Res Pract       Date:  2020-08-13       Impact factor: 1.866

2.  Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration.

Authors:  Michiel L Bots; Karlijn A Groenewegen; Todd J Anderson; Annie R Britton; Jacqueline M Dekker; Gunnar Engström; Greg W Evans; Jacqueline de Graaf; Diederick E Grobbee; Bo Hedblad; Albert Hofman; Suzanne Holewijn; Ai Ikeda; Maryam Kavousi; Kazuo Kitagawa; Akihiko Kitamura; M Arfan Ikram; Eva M Lonn; Matthias W Lorenz; Ellisiv B Mathiesen; Giel Nijpels; Shuhei Okazaki; Daniel H O'Leary; Joseph F Polak; Jacqueline F Price; Christine Robertson; Christopher M Rembold; Maria Rosvall; Tatjana Rundek; Jukka T Salonen; Matthias Sitzer; Coen D A Stehouwer; Oscar H Franco; Sanne A E Peters; Hester M den Ruijter
Journal:  Hypertension       Date:  2014-03-10       Impact factor: 10.190

3.  High efficient and cost-effective screening method for diabetic cardiovascular risk.

Authors:  Tadafumi Kajimoto; Mami S Sawamura; Reiko D Hayashi; Takeshi Oya; Rieko A Hirao; Haruhiko Kouhara
Journal:  Diabetol Metab Syndr       Date:  2014-04-08       Impact factor: 3.320

4.  Cohort Profile: The Nijmegen Biomedical Study (NBS).

Authors:  Tessel E Galesloot; Sita H Vermeulen; Dorine W Swinkels; F de Vegt; B Franke; M den Heijer; J de Graaf; André L M Verbeek; Lambertus A L M Kiemeney
Journal:  Int J Epidemiol       Date:  2017-08-01       Impact factor: 7.196

5.  Risk Stratification of Patients with Peripheral Arterial Disease and Abdominal Aortic Aneurysm Using Aortic Augmentation Index.

Authors:  Marianne Beckmann; Vincenzo Jacomella; Malcom Kohler; Mario Lachat; Amr Salem; Beatrice Amann-Vesti; Marc Husmann
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.